The purpose of this study is to characterise how rare histologic types of breast cancer differ in their stage, size, lymph node status, oestrogen receptor (ER)/PR status, and grade, utilizing data from 11 population-based tumour registries that participate in the Surveillance, Epidemiology, and End Results (SEER) Program. This evidence concerns the gene PGR and breast cancer.